Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Pharmaceutical News Stories - November 2011

Date Title Comments Rating
2011-11-30 Watson commences shipping of generic LIPITOR 0 None
2011-11-30 One-time injection after spinal cord injury can limit pain for 8 months 0 None
2011-11-30 Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor 0 None
2011-11-30 Pfizer backs its highest grosser Lipitor 0 None
2011-11-30 Dramatic nationwide rise in opioid use for chronic abdominal pain 0 None
2011-11-30 Groups push for legislation to encourage Medicaid programs to use generic drugs 0 None
2011-11-30 Lapatinib could extend survival in women with Her2-positive breast cancer 0 None
2011-11-30 Associated Press examines Chinese vaccine makers' entry into international market 0 None
2011-11-30 Legalization of medical marijuana reduces traffic fatalities, alcohol consumption 0 None
2011-11-30 DNA gyrase B could rapidly eliminate TB, shorten treatment time 0 None
2011-11-29 FDA approves Watson's ANDA for generic Yaz oral contraceptive 0 None
2011-11-29 FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation 0 None
2011-11-29 EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome 0 None
2011-11-29 UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication 0 None
2011-11-29 Avita Medical announces acquisition of intellectual property from McComb Foundation 0 None
2011-11-29 HealthWarehouse.com launches pre-order program for generic Lipitor 0 None
2011-11-29 Ferrer introduces citicoline oral solution medical food 0 None
2011-11-29 Seizure drug slows spread of uveal melanoma 0 None
2011-11-29 Combination of other opioids with methadone therapy can lead to overdose or fatal consequences 1 None
2011-11-28 FDA approves Mylan's generic Dexrazoxane for Injection ANDA 0 None
2011-11-28 European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes 0 None
2011-11-28 FDA grants Perrigo final approval for Guaifenesin Extended-Release Tablets ANDA 0 None
2011-11-28 New creative uses of DNA 'barcoding' 0 None
2011-11-27 Drug for midnight waking gets FDA approval 0 None
2011-11-25 Moleac launches NurAiD II in France and Belgium 0 5
2011-11-24 Just a few drugs responsible for majority of emergency hospitalizations 0 None
2011-11-24 Acetaminophen over-use can lead to serious liver damage 0 None
2011-11-24 Merck agrees to pay $950 million in Vioxx settlement 0 None
2011-11-24 Obama should announce scale-up of AIDS treatment programs 0 None
2011-11-24 Study looks at effects of antipsychotic drugs on two brain receptors linked to schizophrenia 0 None
2011-11-24 Five ways pharmaceutical companies can address NTDs 0 None
2011-11-24 Combination of radiation treatment and LY2109761 can prevent glioblastoma 0 None
2011-11-24 Anesthesia drug shortages can have devastating impact on patient care 0 None
2011-11-24 Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes 0 None
2011-11-24 Two-drug combination may alleviate radiation sickness in people 0 None
2011-11-24 Metformin prevents growth of breast cancer cells in human cultures 0 None
2011-11-24 Bloomberg examines Trans-Pacific Partnership trade initiative and potential impact to U.S. global efforts to tackle HIV 0 None
2011-11-24 FDA takes legal action against dietary supplement manufacturer in Pennsylvania 0 None
2011-11-23 Advaxis completes ADXS-HER2 pre-IND meeting with FDA 0 None
2011-11-23 Transcept receives FDA approval for Intermezzo to treat insomnia 0 None
2011-11-23 Cancer medicine component could prevent heart attacks 0 None
2011-11-23 University of Rochester receives U.S. patent for HPV vaccine research 0 None
2011-11-23 Study reveals principal mechanism of action for paracetamol 0 4
2011-11-23 Medicare to cover infusion costs for prostate cancer vaccine, company says 0 None
2011-11-23 Families with chronically ill member less likely to benefit from employer-sponsored insurance 0 None
2011-11-23 USPTO issues patent to BioFactura's StableFast platform 0 None
2011-11-23 L-tyrosine could help treat Nemaline Myopathy in children 2 None
2011-11-23 Oral antibiotics might treat Buruli ulcer 0 None
2011-11-22 FDA accepts Regeneron's ARCALYST sBLA for review 0 None
2011-11-22 Naltrexone for problem gamblers 0 None
2011-11-22 Merck agrees to pay $950 million in Vioxx safety probe 0 None
2011-11-22 Essence Healthcare, CompCare sign new multi-service agreement 0 None
2011-11-22 Eating fish before age of nine months reduces risk of pre-school wheeze in children 0 None
2011-11-22 New way to exploit expression of BRAF by papillary carcinomas for therapeutic purposes 0 None
2011-11-22 Medicare will still cover Avastin for breast cancer, despite revocation of FDA approval 0 None
2011-11-22 Decanoic acid can modulate glucose control 0 None
2011-11-22 FDA accepts Otsuka's aripiprazole depot formulation NDA for review 0 None
2011-11-22 New way to enhance effects of anandamide in the body 0 None
2011-11-22 'WHPA Prague Call to Action' fights against falsified medicines 0 None
2011-11-22 Researchers identify EGFR protein as therapeutic target for Cushing disease 0 None
2011-11-22 Oral delivery of PYY hormone can help obese people lose weight 0 4
2011-11-22 Older home health care patients are prescribed PIMs three times higher than others 0 None
2011-11-21 Cisplatin anti-cancer drug binds pervasively to RNA 0 None
2011-11-21 USPTO to issue patent for CU's DCA to treat cancer 0 None
2011-11-21 Regeneron’s Eylea for treating age related macular degeneration gets FDA nod 0 5
2011-11-21 Breast cancer drug Avastin loses FDA support 0 None
2011-11-21 Despite market constraints, the drug market for key hospital-treated infections will increase: Report 0 None
2011-11-21 Viewpoints: Finding savings in Medicare; The Avastin saga; Changes in health care business 0 None
2011-11-21 The Chinese acute coronary syndrome drug market to grow from $326M in 2010 to $448M in 2015 0 None
2011-11-21 ChanRx to evaluate AFIB drug, vanoxerine with closed Series A funding 0 None
2011-11-21 SAFC commences process validation activities for Oncolytics' REOLYSIN 0 None
2011-11-21 Australia's TGA grants market authorisation for Pierre Fabre Médicament's milnacipran to treat fibromyalgia 0 None
2011-11-21 PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic 0 4
2011-11-21 Impax initiates patent challenge related to Fentora 0 None
2011-11-21 IGI develops and submits two more ANDAs to the FDA 0 None
2011-11-21 Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes 0 None
2011-11-21 Cambridge Theranostics' liquidators set deadline for offers 0 None
2011-11-21 Mylan settles Vivelle-Dot patent litigation lawsuit with Novartis 0 None
2011-11-21 ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement 0 None
2011-11-21 ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris 0 None
2011-11-21 Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak 0 None
2011-11-21 Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea 0 None
2011-11-19 Switching or adding antidepressants does not exacerbate side effects 0 None
2011-11-19 Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy 1 3.3
2011-11-19 New class of malaria drugs could be used as both prevention, treatment, study shows 0 None
2011-11-19 Avastin drug not safe and effective for breast cancer patients: FDA Commissioner 0 None
2011-11-19 FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia 0 None
2011-11-19 Shire, Shionogi enter agreement to co-develop and co-commercialize ADHD medicines in Japan 0 None
2011-11-19 FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer 0 None
2011-11-19 FDA revokes approval of Avastin for breast cancer 0 None
2011-11-19 FDA approves EYLEA for treatment of wet Age-related Macular Degeneration 0 None
2011-11-18 Kremers Urban to resolve Lipitor litigation 0 None
2011-11-18 Regeneron receives FDA approval for Eylea to treat wet AMD 0 None
2011-11-18 EUSA Pharma receives FDA approval for Erwinaze to treat ALL 0 None
2011-11-18 H2S plays a major role in protecting bacteria from effects of different antibiotics 0 None
2011-11-18 Multi-drug resistant bacteria widespread in Europe, report says 0 None
2011-11-18 VSL#3 classified as refrigerated medical food for three GI conditions 0 5
2011-11-18 IDSA supports 'Get Smart About Antibiotics Week' 0 None
2011-11-18 South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports 0 None
2011-11-18 Norway to focus on unnecessary use of antibiotics for asymptomatic UTI 0 None
2011-11-18 Two RegeneRx cardiac-related patents receive notice of allowance in Australia, Mexico 0 None
2011-11-18 Chloroquine-chemotherapy combination holds potential for metastatic breast cancer treatment 0 None
2011-11-17 Scientists discover family of chemical compounds that could prevent malaria 0 None
2011-11-17 EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy 0 None
2011-11-17 Psychiatric medication use soaring among women: Report 1 None
2011-11-17 Tripling clopidogrel dosage improves platelet reactivity in cardiac patients 0 None
2011-11-17 Kentucky Circuit Court rules in favor of Watson in drug pricing litigation 0 None
2011-11-17 20% of U.S. adults take psychiatric drugs 0 None
2011-11-17 New treatment may be on the horizon for neuroendocrine prostate cancers 0 None
2011-11-17 Probiotic before radiation therapy can protect intestine from damage 0 5
2011-11-17 Male breast cancer patients report tamoxifen side effects 0 None
2011-11-17 TNF inhibitors may minimally increase risk of serious infections 0 None
2011-11-17 WSU researchers to study novel antibiotic that may treat VRE infection 0 None
2011-11-17 Mannosides show promise against urinary tract infections 0 5
2011-11-17 Multivitamin use linked to less healthy behaviors 1 1
2011-11-17 Malawi government addressing drug, medical supply shortages in wake of aid withdrawals 0 None
2011-11-17 People with prior stroke or diabetes benefit from thrombolytic therapy 0 None
2011-11-17 Dipyrone may reduce brain damage after stroke 0 None
2011-11-17 Incyte receives FDA approval for Jakafi to treat intermediate or high-risk MF 0 None
2011-11-16 Excessive vitamin D levels can lead to onset of AF 1 None
2011-11-16 Mirna reports new preclinical data of miRNA-based therapeutic candidate for hepatocellular carcinoma 0 None
2011-11-16 Cholesterol drugs clash head on 0 None
2011-11-16 Geron bows out of stem cell research 0 None
2011-11-16 Atherosclerotic plaques spread downstream in coronary arteries 0 None
2011-11-16 ZIOPHARM announces new preclinical data from two darinaparsin studies on solid tumors 0 None
2011-11-16 Amgen receives EC approval to extend therapeutic indications for Vectibix 0 None
2011-11-16 Advaxis licenses ISG15 tumor antigen from University of Pennsylvania 0 None
2011-11-16 Niacin not effective in reducing risk of stroke, heart attack in stable CV patients 0 None
2011-11-16 Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality 0 None
2011-11-16 International consortium develops first-in-class adiponectin receptor agonist 0 None
2011-11-16 Evacetrapib drug may increase HDL-C and decrease LDL-C levels 0 None
2011-11-16 Changing priorities for major generic drug producers could lead to rising drug prices in developing countries 0 None
2011-11-16 Silibinin stops spread of lung cancer in mice 0 None
2011-11-15 EPO-secreting engineered vessels could reverse anemia 0 None
2011-11-15 Pneumococcal vaccine Prevnar13 effective in seniors 0 None
2011-11-15 Xarelto (rivaroxaban) shows success as blood thinner in acute coronary syndrome 0 None
2011-11-15 Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts 0 None
2011-11-15 Scil Proteins completes manufacturing agreement with Lundbeck 0 None
2011-11-15 Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients 0 None
2011-11-15 Tigecycline antibiotic shows promise against leukemia 0 4.7
2011-11-15 Eliminating drug co-pays improves medication adherence in heart attack patients 0 None
2011-11-15 CDC launches new antibiotic tracking system 0 None
2011-11-15 Experts discuss treatment as prevention at USAID-, World Bank-sponsored debate 1 None
2011-11-15 Multiple medication use may increase severity of erectile dysfunction 0 None
2011-11-15 PROMETAT no more effective than placebo in reducing methamphetamine use 0 None
2011-11-15 New technology speeds up 'near real-time' vaccination data collection 0 None
2011-11-15 Scientists discover promising approaches for treatment of pain 0 None
2011-11-14 Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals 0 None
2011-11-14 Stem cell bandage human clinical trial for torn meniscal cartilage 0 None
2011-11-14 Cancer drug joins list of medicines in short supply 0 None
2011-11-14 BIDMC researcher says improvement in survival rates best 'since introduction of aspirin' 0 None
2011-11-14 Dyax and Defiante decide to withdraw KALBITOR MAA filed with EMA 0 None
2011-11-14 FDA approves Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL 0 None
2011-11-14 Scientists discover molecular basis for tamoxifen resistance and potential way to defeat it 0 None
2011-11-14 Scientists create new phenotypic cancer drug screening platform 0 None
2011-11-14 Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma 0 None
2011-11-14 ZIOPHARM announces darinaparsin preclinical data on prostate cancer 0 None
2011-11-14 Combination of REGN910 and aflibercept inhibits tumor angiogenesis in animal models 0 None
2011-11-14 Researchers show how ER-positive breast cancer tumors become resistant to tamoxifen 0 None
2011-11-14 Low levels of vitamin C associated with worse outcomes for heart failure patients 0 None
2011-11-13 Older patients less likely to receive pain medication in hospital EDs 0 None
2011-11-13 IVI receives WHO prequalification for new oral cholera vaccine 0 None
2011-11-13 Opioid-dependent patients have worse outcomes before knee replacement surgery 0 None
2011-11-13 Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz 0 None
2011-11-13 NICE refuses AstraZeneca breast cancer drug on NHS 0 None
2011-11-11 Inflammatory arthritis or autoimmune disease ruled out as cause for joint pain associated with AIs 0 None
2011-11-11 Actavis begins shipping Morphine Sulfate Extended-Release Capsules 0 None
2011-11-11 Vaccination dramatically reduces incidence of Hib disease in young children 0 None
2011-11-11 Worm model to evaluate drugs for Parkinson's disease 0 None
2011-11-11 New process allows for more rapid and cheaper separation of enantiomers 0 None
2011-11-11 Pharmaceutical industry should invest more in NTDs 0 4
2011-11-11 N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis 0 None
2011-11-11 Watson receives FDA approval for generic Kadian ANDA 0 None
2011-11-11 Intelligent Fingerprinting launches prototype of hand-held drug testing device 0 None
2011-11-11 Novartis files suit against Watson over generic Exelon 0 None
2011-11-10 CCCBD scientist to receive 2011 V Foundation Translational Research Grant 0 None
2011-11-10 Mylan acquires rights to Pfizer's inhalation technology platform 0 None
2011-11-10 HFHP now able to offer two stand-alone prescription drug plans statewide 0 None
2011-11-10 APS supports CDC's call for multifaceted approach to address prescription drug misuse 0 None
2011-11-10 Aristolochic acid leads to kidney failure, upper urinary tract cancer 0 None
2011-11-10 Merck's NEXPLANON 68 mg now available in the U.S. 0 1
2011-11-10 Study: Omega-3 supplements can decrease inflammation, anxiety 0 None
2011-11-10 PCMD researcher receives Alzheimer's Association grant to study dementia 0 None
2011-11-10 Patients with Parkinson's may have increased risk of leg motor restlessness 0 None
2011-11-10 New epigenetic therapy may treat recurrent metastatic NSCLC 0 None
2011-11-09 Another tool to fight pharmacy crime through Twitter 0 None
2011-11-09 Study reveals need for defining optimal amount of iron in infant formula 0 None
2011-11-09 Salix third quarter total product revenue increases 81% to $146.2 million 0 None
2011-11-09 Viagra may improve antitumor immunity in people with melanoma 0 None
2011-11-09 Amylin and Lilly terminate exenatide alliance, resolve litigation 0 None
2011-11-09 FDA accepts Genentech's vismodegib NDA for review 0 None
2011-11-09 QRxPharma receives FDA written acceptance for review of MoxDuo IR NDA 0 None
2011-11-09 Micell announces preliminary data from MiStent Sirolimus DES clinical study 0 None
2011-11-09 BioSpecifics reports $0.3M net income for third quarter 2011 vs. $0.5M net loss for third quarter 2010 0 None
2011-11-08 Lapatinib drug could also treat head and neck cancers 0 None
2011-11-08 FDA grants Fast Track designation to Opexa's Tovaxin for treatment of SPMS 1 None
2011-11-08 UM launches campaign on medication adherence in Baltimore 0 None
2011-11-08 QRxPharma receives date for US pain drug launch, pending approval 0 None
2011-11-08 Congress examines options to improve availability of prescription drugs 0 None
2011-11-08 Children's Hospital project to investigate effectiveness of BET antagonists against HIV 0 None
2011-11-08 Live virus used in polio vaccine can evolve and infect, warns TAU researcher 0 None
2011-11-08 Georgia Tech/CDC project focuses on microneedle patches for polio vaccination 1 5
2011-11-08 Link between heavy methamphetamine use and schizophrenia 0 None
2011-11-08 Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer 0 5
2011-11-07 A prescription for prevention 0 None
2011-11-07 DSM and Svelte Medical Systems enter into license and supply agreement 0 None
2011-11-07 Perrigo and Synthon commence shipping generic Xyzal Oral Solution 0 None
2011-11-07 Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020 0 None
2011-11-07 DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe 0 None
2011-11-07 MILV subsidiary acquires formula to restore proper kidney function 0 None
2011-11-07 Study: Young adults in the north west of England consume illegal drugs after mephedrone ban 0 None
2011-11-07 Scientists achieve major step toward goal of producing synthetic Taxol 0 None
2011-11-07 Study evaluates JIA disease activity after treatment with etanercept 0 None
2011-11-07 PKM2 enzyme has important non-metabolic functions in cancer formation 0 None
2011-11-07 Narcotic analgesics increase risk of falls and fractures among elderly 0 None
2011-11-07 Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA 0 None
2011-11-07 Biologics reduce fatigue in people with RA 0 None
2011-11-07 IFNa-kinoid shows promise against lupus 0 None
2011-11-07 Link between use of anti-TNF therapy and malignant melanoma in RA patients 0 None
2011-11-06 Doctors may stop anti-TNF medications for RA patients before surgery to reduce disease flares 0 None
2011-11-05 Supplemental dose of pneumonia vaccine recommended for age-eligible patients 0 None
2011-11-05 APF launches new online educational module on safe use of CAM 0 None
2011-11-05 Octapharma receives FDA approval for octagam to treat disorders of immune system 0 None
2011-11-05 Janssen receives FDA approval for Xarelto to prevent stroke in people with AF 0 None
2011-11-04 Vitamin D levels not related to acute exacerbations of chronic obstructive pulmonary disease 0 None
2011-11-04 Baxter launches NUMETA emulsion for infusion in Europe 0 None
2011-11-04 Kenyan company receives WHO prequalification for generic ARV 0 None
2011-11-04 Avoiding sun may increase risk of vitamin D deficiency in light-skinned people 0 None
2011-11-04 Financial investment, progress in HIV/AIDS treatment must be protected by international patent law 0 None
2011-11-04 Cancer drug shortage relates to economics 0 None
2011-11-04 Glaxo pays $3 billion to settle investigations involving alleged marketing missteps and Medicaid fraud 0 None
2011-11-04 Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking' 0 None
2011-11-04 Amphetamine use in adolescence can affect brain chemistry and behaviour 0 None
2011-11-04 TPI announces formulation expansion program for GMOL 0 None
2011-11-04 Escitalopram reduces pain severity, interference in opioid-dependent patients 0 None
2011-11-04 FDA accepts VIVUS' Qnexa NDA for filing and review 0 None
2011-11-04 Bristol-Myers Squibb, ASLAN partner to develop BMS-777607 for solid tumors 0 None
2011-11-04 A prescription for prevention 0 None
2011-11-03 Merck’s cholesterol lowering drug gets FDA panel’s vote 0 None
2011-11-03 Savient third quarter net loss decreases to $27.4 million 0 None
2011-11-03 POZEN third quarter revenue increases to $4.9 million 0 None
2011-11-03 CMS issues J-code for Savient's KRYSTEXXA 0 None
2011-11-03 FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD 0 None
2011-11-03 EBV vaccine could prevent mononucleosis and cancers linked to virus 0 4
2011-11-03 Exendin-4 drug could prevent later development of diabetes in children 0 5
2011-11-03 Synthetic artemisinin discovery could make malaria treatments more affordable, accessible 0 None
2011-11-03 Benefits of combined therapy for men with high-risk prostate cancer 0 None
2011-11-03 Exenatide's rapid anti-inflammatory effect may inhibit atherosclerosis 0 None
2011-11-03 Researchers use diabetes drug to permanently reprogram insulin-producing cells 0 None
2011-11-03 Allergy shots are cost-effective and deliver relief in weeks 0 None
2011-11-03 Promedior's Pentraxin-2 effectively suppresses liver fibrosis 0 None
2011-11-03 UC Merced professor designs powerful chemical inhibitor against HIV 0 None
2011-11-03 Nicotine might prime the brain to enhance behavioral effects of cocaine 0 None
2011-11-03 Many spinal fusion surgery patients have low levels of vitamin D 0 None
2011-11-03 FDA approves Endo Pharmaceuticals' Felodipine Extended-release Tablets 0 None
2011-11-02 ADHD drugs don’t raise risk for heart attacks or stroke: Study 1 None
2011-11-02 Americans overdosing on prescription pain killers 0 None
2011-11-02 Prescription drug shortages: Endocrine Society calls for mandatory reporting by manufacturers 0 4
2011-11-02 Scientists identify distinct tobacco transporter for nicotine metabolism 0 None
2011-11-02 Researchers identify small-molecule drug candidates for many metabolic conditions 0 None
2011-11-02 Obama takes action to address drug shortages 1 None
2011-11-02 Prostate cancer patients with bone metastases benefit from repeated 188Re-HEDP therapy 0 None
2011-11-02 ADHD medications do not increase risk of heart attack in children, young adults 0 None
2011-11-02 Birth control shot may impair a person's memory 0 None
2011-11-02 No link between anti-clotting drugs and increased risk of bleeding in GI procedure 0 None
2011-11-02 SurModics to sell Pharma assets to Evonik for $30 million 0 None
2011-11-02 SmartTots sets agenda for research on anesthetic safety in children 0 None
2011-11-02 High dose of vitamin D3 safe and effective for obese adolescents 0 None
2011-11-02 Takeda receives FDA approval for VELCADE sNDA to treat MM 0 None
2011-11-02 Glyphosine can prevent development of type 1 diabetes 0 None
2011-11-02 FDA approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System 0 None
2011-11-02 Perrigo's partner receives final approval for Epinastine HCl ophthalmic solution 0 None
2011-11-01 ProPhase Labs introduces new Cold-EEZE Oral Spray 0 None
2011-11-01 National lupus organizations urge NICE to recommend Benlysta for coverage 0 None
2011-11-01 Internet-based communication improves teenagers' use of topical acne therapy 0 None
2011-11-01 LA BioMed's lead investigator hopes to bring PAH awareness this November 0 None
2011-11-01 Potential role for UV light exposure, vitamin D levels in chronic digestive conditions 0 None
2011-11-01 Azantis introduces reduced glutathione and vitamin C liposomal products 0 None
2011-11-01 PerkinElmer launches new NexION ES Software for pharma companies 0 None

Total

279 posts
12 comments
23 raters